Equity
Common Stock Shares Outstanding
Guardant Health Common Stock Shares Outstanding decreased by 15.9% to $261.06M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 247.7%, from $75.09M to $261.06M. Over 5 years (FY 2020 to FY 2025), Common Stock Shares Outstanding shows a downward trend with a -2.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
First reportedQ4 2017
Last reportedQ1 2026May 7, 2026
Metric ID:
common_stock_shares_outstandingHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $288.75M | $259.45M | $193.01M | $115.46M | $66.64M | $93.8M | $39.75M | $32.77M | $55.49M | $43.28M | $39.12M | $27.04M | $31.29M | $21.3M | $35.98M | $75.09M | $113.88M | $158.07M | $310.47M | $261.06M |
| QoQ Change | — | -10.1% | -25.6% | -40.2% | -42.3% | +40.7% | -57.6% | -17.6% | +69.3% | -22.0% | -9.6% | -30.9% | +15.7% | -31.9% | +68.9% | +108.7% | +51.7% | +38.8% | +96.4% | -15.9% |
| YoY Change | — | — | — | — | -76.9% | -63.8% | -79.4% | -71.6% | -16.7% | -53.9% | -1.6% | -17.5% | -43.6% | -50.8% | -8.0% | +177.7% | +263.9% | +642.0% | +762.9% | +247.7% |
Range$21.3M – $310.47M
CAGR-2.1%
Avg YoY Growth+100.6%
Median YoY Growth-17.1%
Common Stock Shares Outstanding at Other Companies
Frequently Asked Questions
- What is Guardant Health's common stock shares outstanding?
- Guardant Health (GH) reported common stock shares outstanding of $261.06M in Q1 2026.
- How has Guardant Health's common stock shares outstanding changed year-over-year?
- Guardant Health's common stock shares outstanding increased by 247.7% year-over-year, from $75.09M to $261.06M.
- What is the long-term trend for Guardant Health's common stock shares outstanding?
- Over 5 years (2020 to 2025), Guardant Health's common stock shares outstanding has grown at a -2.4% compound annual growth rate (CAGR), from $350.67M to $310.47M.